The vast majority of lasers used in medicine, cosmetics, and consumer products do not cause cancer. Over more than 25 years of clinical use, aesthetic and surgical lasers have produced no evidence of a credible cancer risk in patients. The reason is straightforward: most medical and cosmetic lasers emit light in the visible or near-infrared spectrum, wavelengths that lack the energy to damage DNA the way ultraviolet radiation or X-rays do. But the full picture has a few wrinkles worth understanding, from a narrow class of UV-emitting lasers that do interact with DNA, to lab findings about low-power lasers and cancer cells, to an occupational hazard that has nothing to do with the laser beam itself.
Why Wavelength Is the Key Distinction
Cancer starts with damage to DNA. Ultraviolet radiation and ionizing radiation (like X-rays and gamma rays) carry enough energy per photon to break chemical bonds in DNA strands or to generate reactive molecules that tear into DNA indirectly. UV photons are absorbed directly by the building blocks of DNA, creating the kind of mutations that can eventually lead to uncontrolled cell growth. Ionizing radiation goes further, ejecting electrons from atoms and producing highly reactive molecules that attack DNA from multiple angles.
Lasers, though, are simply concentrated beams of light at a specific wavelength. A red laser pointer, a near-infrared hair-removal laser, and a green surgical laser all emit photons with far less energy per photon than UV light. They interact with tissue mainly through heat. When a dermatologist fires a laser at your skin, the beam is absorbed by a target (pigment, blood, water) and converted to thermal energy. That heat can destroy the target tissue, but it does not alter the genetic code the way UV or ionizing radiation does. The distinction between “thermal damage” and “DNA-mutating damage” is central to why these devices do not initiate cancer.
The Track Record of Aesthetic and Surgical Lasers
Dermatological lasers have been in widespread clinical use since the early 1990s for everything from hair removal and tattoo fading to scar revision and vascular lesion treatment. A review of this evidence base concluded that more than 25 years of laser and intense pulsed light use has not raised concerns about long-term cancer risk, with only a handful of anecdotal melanoma cases reported after treatment across two decades of practice.1PubMed Central. Lasers and intense pulsed light (IPL) association with cancerous lesions Those isolated case reports have never been linked causally to the laser treatment itself; in most instances, the concern is that a laser procedure might have been performed on skin that already harbored a melanoma that went unrecognized.
Animal research tells a similar story. In hairless mice, a standard treatment with a copper vapor laser showed no cancer-causing potential on its own. At the highest intensity tested, the laser actually delayed the onset of UV-induced skin cancer compared to UV exposure alone.2Acta Dermato-Venereologica. Cutaneous side effects from laser treatment of the skin: skin cancer, scars, wounds, pigmentary changes, and purpura–use of pulsed dye laser, copper vapor laser, and argon laser A more recent study using fractional CO₂ laser on UV-exposed mice found that repeated laser treatments delayed squamous cell carcinoma development and reduced visible and microscopic signs of sun damage in the skin.3PubMed Central. Repeated exposure to fractional CO2 laser delays squamous cell carcinoma formation and prevents clinical and subclinical photodamage visualized by line‐field confocal optical coherence tomography and histology These are mouse experiments, so they should not be over-interpreted as proof that lasers prevent cancer in humans. But they do reinforce the point that the thermal and wound-healing effects of these lasers are not nudging cells toward malignancy.
UV-Emitting Lasers Are the Exception
Not all lasers operate at safe wavelengths. Excimer lasers, used in certain eye surgeries and specialized dermatological treatments, emit in the ultraviolet range. These UV lasers, operating at wavelengths like 193 nm, 248 nm, and 308 nm, cause the same DNA photochemistry as conventional UV light sources at comparable wavelengths. The high intensity of the excimer beam does not create a different type of damage; it produces the same mutations that lower-intensity UV sources do.4PubMed. Cytotoxicity and mutagenicity of excimer laser radiation
In practice, the cancer risk from medical UV lasers turns out to be very small. A risk assessment of long-term occupational exposure to UV lasers in the 190–400 nm range found that for typical medical applications, the added skin cancer risk was comparable to about one extra day of sunbathing per year. For laboratory workers who handle UV lasers regularly, the risk could rise to levels comparable to people who work outdoors for a living.5PubMed. Evaluation of skin cancer risk resulting from long term occupational exposure to radiation from ultraviolet lasers in the range from 190 to 400 nm That is not zero, but it puts the hazard in perspective: it is a manageable occupational exposure, not an acute danger, and it applies to UV lasers specifically, not to the infrared and visible-light lasers that make up the overwhelming majority of clinical and consumer devices.
Low-Level Laser Therapy and the In Vitro Question
Low-level laser therapy (LLLT), sometimes called photobiomodulation, uses very low power settings, typically red or near-infrared light, to stimulate healing, reduce pain, or manage inflammation. The beam does not cut or burn tissue. Instead, it delivers a modest dose of light energy that appears to influence cellular metabolism. This has raised a different kind of cancer question: if LLLT can stimulate cell activity, could it also stimulate cancer cells to grow faster?
The lab evidence here is genuinely mixed. One study exposed isolated cancer cells to low-level laser light and found that proliferation rates increased with repeated applications, leading the researchers to warn that LLLT could theoretically activate precancerous cells or accelerate existing cancerous tissue.6PubMed Central. Low level laser therapy induces increased viability and proliferation in isolated cancer cells Another study found that irradiation with 670 nm laser light significantly increased proliferation of laryngeal cancer cells in culture compared to non-irradiated controls.7PubMed. Effects of low-level laser therapy on malignant cells: in vitro study
These findings sound alarming, but there is an important caveat: they come from cells growing in dishes, not from living organisms. The behavior of isolated cancer cells bathed in laser light in a laboratory does not necessarily translate to what happens inside a human body, where immune surveillance, blood supply, and surrounding tissue all play roles. A preliminary animal study that exposed tumors in living mice to red-light LLLT found no measurable effect on tumor growth, suggesting that the therapy may be safe even when malignant lesions are present.8PubMed Central. A Preliminary Study of the Safety of Red Light Phototherapy of Tissues Harboring Cancer
The honest summary is that LLLT does not appear to initiate cancer (it does not damage DNA), but there is legitimate uncertainty about whether it could encourage existing cancer cells to grow. For people with known malignancies or precancerous lesions, this is a reasonable conversation to have with a doctor before undergoing LLLT. For the general population getting low-level laser treatments for pain or cosmetic purposes, the existing evidence does not point to meaningful risk.
Surgical Smoke Is the Overlooked Hazard
When people worry about lasers and cancer, they are almost always thinking about the beam itself. But the most documented cancer-related hazard in laser use has nothing to do with the light. It is the smoke. When surgical lasers (or electrocautery devices) vaporize tissue during an operation, they generate a plume of airborne particles. Systematic reviews of this surgical smoke have found that it contains carcinogenic compounds, including formaldehyde, benzene, and other volatile organic chemicals, sometimes at concentrations exceeding occupational safety limits.9Health Sciences Review. A systematic review of the harmful effects of surgical smoke inhalation on operating room personnel The International Agency for Research on Cancer classifies several of these compounds as carcinogenic to humans.
Multiple studies have identified toxic and carcinogenic chemicals in the smoke generated by CO₂ lasers and electrosurgical instruments, including benzene, toluene, and acrolein.10PubMed Central. Impact of Surgical Smoke on the Surgical Team and Operating Room Nurses and Its Reduction Strategies: A Systematic Review This is primarily a concern for operating room staff who breathe the plume day after day, not for patients undergoing a single procedure. Surgeons, nurses, and technicians who work with tissue-vaporizing lasers routinely are the population at risk, and the standard mitigation is smoke evacuation equipment that captures the plume before it disperses into the room. In practice, adoption of proper smoke evacuation varies widely across hospitals, which means the occupational hazard persists in many settings.
If you are a patient having a laser procedure, the smoke exposure from a single session is trivial. If you work in an operating room where lasers or electrosurgery are used daily, pushing for consistent use of smoke evacuators is one of the more practical things you can do to reduce a real, if incremental, occupational cancer risk.
Common Misconceptions About Lasers and Cancer
A survey of dermatology patients found that roughly one in five believed laser treatment could cause skin cancer.11PubMed. Misconceptions about laser treatment among dermatology patients The same survey revealed that about 10% of respondents thought lasers were a form of nuclear radiation. These misunderstandings likely stem from the word “radiation” itself: in everyday language, radiation is associated with nuclear fallout and X-ray machines, both of which carry real cancer risks. But laser light is non-ionizing radiation, a category that also includes radio waves, microwaves, and the visible light coming from your desk lamp. The word “radiation” in the acronym LASER (Light Amplification by Stimulated Emission of Radiation) refers to how the light is emitted, not to any nuclear process.
Another common confusion involves laser hair removal and skin cancer. People notice that the treated skin sometimes reddens or darkens temporarily and worry that the laser is causing the type of damage that leads to melanoma. What is actually happening is a brief inflammatory response and, occasionally, a temporary change in pigment production. The wavelengths used in hair removal (typically 755 nm, 810 nm, or 1064 nm) target melanin in the hair follicle and convert it to heat. That heat destroys the follicle, not the DNA of surrounding skin cells. Temporary side effects like redness and pigment changes are cosmetic and resolve, and they are not precursors to malignancy.
A related worry is that laser tattoo removal might cause cancer, since the process breaks down ink particles that are then cleared by the body. The concern usually centers on whether fragmented ink pigments could be toxic or mutagenic as they circulate. Tattoo inks themselves are a complex cocktail of chemicals, and there is growing scientific interest in their toxicology. But no clinical evidence links laser tattoo removal to cancer development. The fragmented particles are processed by the same immune cells that were already surrounding and containing the intact ink.
When Lasers Are Used to Fight Cancer
It is worth noting that lasers are themselves a cancer treatment tool. Photodynamic therapy (PDT) uses a light-sensitive drug that accumulates preferentially in tumor tissue. When a laser at the right wavelength illuminates the area, the drug reacts with oxygen to produce reactive molecules that destroy the cancer cells. PDT is used for certain skin cancers, esophageal cancers, and lung cancers, among others.12PubMed Central. Photodynamic Therapy Review: Principles, Photosensitizers, Applications, and Future Directions The selectivity comes from the drug’s affinity for tumor tissue and the fact that only the illuminated area is affected, sparing surrounding healthy tissue more effectively than many conventional treatments.
High-power surgical lasers are also used to excise or vaporize tumors directly, particularly in areas where precision matters, like the vocal cords, cervix, or retina. In these applications, the laser’s ability to cut with extreme precision and cauterize blood vessels simultaneously makes it a preferred surgical tool. The laser is killing cancer cells, not creating them.
Anti-Inflammatory Effects of Low-Level Laser Light
One area of active research that may seem surprising given the cancer-cell-proliferation findings is the anti-inflammatory effect of photobiomodulation. Animal studies have shown that red and near-infrared light can reduce levels of pro-inflammatory signaling molecules while boosting anti-inflammatory ones. In one mouse study, daily 30-minute treatments with red and near-infrared light for ten days reduced key inflammatory markers in the brain and throughout the body.13PubMed Central. The anti-inflammatory effects of photobiomodulation are mediated by cytokines: Evidence from a mouse model of inflammation A systematic review of intravascular laser irradiation of blood found that the technique increased anti-inflammatory signaling molecules and decreased pro-inflammatory ones.14PubMed. Influence of Intravascular Laser Irradiation of Blood (ILIB) on inflammatory cytokines and nitric oxide in vivo: a systematic review Other research has documented immune-modulating effects of LLLT at the skin and in joints.15PubMed Central. Laser Light Therapy in Inflammatory, Musculoskeletal, and Autoimmune Disease
Since chronic inflammation is itself a recognized driver of certain cancers, some researchers have speculated that the anti-inflammatory properties of low-level laser light might, paradoxically, offer a degree of protection. This is speculative and far from proven, but it illustrates why the relationship between lasers and cancer is more nuanced than a simple yes-or-no framing allows. The same low-power light that can speed up cancer cell growth in a petri dish might reduce the kind of chronic tissue inflammation that fosters cancer development in the body. The two findings are not necessarily contradictory; they reflect different biological contexts and different mechanisms at work.
Home Laser Devices and Safety Standards
The growing market for at-home laser and intense pulsed light devices for hair removal, skin rejuvenation, and acne treatment has introduced new safety considerations. These consumer products contain embedded lasers that would ordinarily be classified as high-hazard (Class 3B or Class 4), but built-in design features, such as skin-contact sensors and safety interlocks, prevent the device from firing unless pressed against the skin, keeping the beam from reaching the eyes.16ILSC 2013: Proceedings of the International Laser Safety Conference. International progress in standards and regulation for light based home use devices International standards have created a new classification (Class 1C) specifically for these consumer devices.
From a cancer standpoint, home devices operate at the same visible and near-infrared wavelengths as their clinical counterparts, just at lower power. The cancer-related considerations are the same: no DNA-damaging capability, no evidence of carcinogenicity. The safety concerns with home devices are burns, eye injury from misuse, and inappropriate treatment of undiagnosed skin lesions. That last point deserves emphasis: if you use a home laser device on a mole or pigmented spot without having it evaluated by a dermatologist, the risk is not that the laser will cause cancer, but that it could alter the appearance of a spot that was already cancerous, making it harder to diagnose later. Any unusual or changing skin lesion should be seen by a professional before being treated with any device, clinical or consumer.